Development of Anticancer Peptides Using Artificial Intelligence and Combinational Therapy for Cancer Therapeutics

Cancer is a group of diseases causing abnormal cell growth, altering the genome, and invading or spreading to other parts of the body. Among therapeutic peptide drugs, anticancer peptides (ACPs) have been considered to target and kill cancer cells because cancer cells have unique characteristics suc...

Descripción completa

Detalles Bibliográficos
Autores principales: Hwang, Ji Su, Kim, Seok Gi, Shin, Tae Hwan, Jang, Yong Eun, Kwon, Do Hyeon, Lee, Gwang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9147327/
https://www.ncbi.nlm.nih.gov/pubmed/35631583
http://dx.doi.org/10.3390/pharmaceutics14050997

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9147327/
https://www.ncbi.nlm.nih.gov/pubmed/35631583
http://dx.doi.org/10.3390/pharmaceutics14050997

Ejemplares similares